サインイン

Laura Heiser

Department of Biomedical Engineering,
Knight Cancer Institute,
Department of Biomedical Engineering, Knight Cancer Institute

Oregon Health and Science University

BIOGRAPHY

Laura Heiser has not added Biography.

If you are Laura Heiser and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer.

Molecular cancer therapeutics Dec, 2017 | Pubmed ID: 28958991

Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer.

Scientific reports Mar, 2019 | Pubmed ID: 30846826

BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancer.

Oncogene Apr, 2019 | Pubmed ID: 30996246

INSTITUTIONS

Oregon Health and Science University

JOVE ARTICLES

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Rebecca Smith¹,

Kaylyn Devlin¹,

David Kilburn¹,

Sean Gross¹,

Damir Sudar²,

Elmar Bucher¹,

Michel Nederlof²,

Mark Dane¹,

Joe W. Gray¹,

Laura Heiser¹,

James E. Korkola¹

¹Department of Biomedical Engineering, Knight Cancer Institute, Oregon Health and Science University,

², Quantitative Imaging Systems LLC

Cancer Research

個人情報保護方針

利用規約

一般データ保護規則

お問い合わせ

図書館への推薦

JoVE ニュースレター

研究

JoVE Journal
メソッドコレクション
JoVE Encyclopedia of Experiments
アーカイブ

教育

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教員向けリソースセンター
教員用サイト

著者

概要
出版プロセス
編集委員会
スコープと指針
査読
よくある質問
お申し込み

図書館員

概要
お客様の声
定期購読
アクセス
リソース
図書館諮問委員会
よくある質問

JoVEについて

概要
経営陣
ブログ
JoVE Help Center

Laura Heiser

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Department of Biomedical Engineering,Knight Cancer Institute,Department of Biomedical Engineering, Knight Cancer Institute

Oregon Health and Science University

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Department of Biomedical Engineering,
Knight Cancer Institute,
Department of Biomedical Engineering, Knight Cancer Institute